A study to evaluate the relationship between body mass index (BMI) and metabolic parameters in schizophrenia patients treated with long-acting injectable paliperidone palmitate
Latest Information Update: 05 Nov 2016
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacodynamics
- 05 Nov 2016 New trial record
- 20 Sep 2016 Results presented at the 29th Annual Congress of the European College of Neuropsychopharmacology